Le Lézard
Classified in: Mining industry, Health, Science and technology

Pharmaceutical Manufacturers Achieve Run Rates of Up to 900 Vials Per Minute with Garvey's Accumulation Systems


BLUE ANCHOR, N.J., Sept. 22, 2020 /PRNewswire-PRWeb/ -- Vials are the most common method of packaging many medicines, particularly injectable vaccines. This is because vials are small, easy to sterilize, and easy to transport. However, vials' small size and light weight also make them unstable on a production line -- if collisions happen or turbulence occurs, they can fall over, potentially causing breakage, product loss, and downtime.

In the past, because of the fragile nature of small vials, the line speeds at which many drugmakers could run their lines was limited. Depending on the product and the process, 400-600 vials per minute was about as fast as most lines could run before vial instability became a significant issue.

Now, with Garvey's accumulation systems that incorporate two patented stability-enhancing features -- pressureless loop technology and a slowdown lane -- pharmaceutical manufacturers can achieve industry-leading line speeds of up to 900 vials per minute.

"Any slow down or interruption in the pharmaceutical manufacturing process can result in people not getting the medicines they need," commented Thomas Garvey, the company's president. "As an OEM serving this industry, we have a responsibility to ensure that our equipment enables drugmakers to produce essential products as quickly and efficiently as possible. By using our accumulation systems, pharmaceutical manufacturers have been able to double, or, in some cases, triple their current line speeds while reducing product damage and downtime."

Garvey's patented pressureless loop technology eliminates collisions and damage by eliminating back pressure. The chain never moves under a stationary product and there are no dead plates the products need to slide over to get to the next conveyor. This prevents damage to the vials as they move around the table.

The patented slowdown lane allows for high-speed outfeed. On a typical accumulation table, where all of the lanes run at the same speed, products approach the outfeed in a nested formation. At the pick off point, the products must be denested, which causes turbulence and, as a result, instability. To solve this problem, Garvey's accumulation systems contain a slowdown lane adjacent to the outfeed lane. When products hit the slowdown lane, which runs 10-15% slower than the rest of the belt, they become stacked rather than nested. Stacked vials are easier to separate without turbulence, which is how the slowdown lane solves the stability problem and supports the highest rate for single-filing in the industry.

Visit the Garvey website to learn more about how these two patented technologies help pharmaceutical manufacturers increase their throughput. If you have any questions or would like to discuss a project, contact the Garvey team.

About Garvey

For nearly 100 years, Garvey Corporation has been a leader in producing conveying, accumulating, and automation solutions that can help manufacturers increase throughput by up to 30%. Garvey's line of solutions includes cutting-edge accumulation tables, rotary tables, conveyors, and more essentials to make your production lines more efficient. Visit Garvey online or follow the company on social media: Facebook, Twitter, YouTube, LinkedIn.

 

SOURCE Garvey Corporation


These press releases may also interest you

at 04:58
Silvercorp Metals Inc. ("Silvercorp") and Adventus Mining Corporation ("Adventus") are pleased to announce that the parties have entered into a definitive arrangement agreement (the "Arrangement Agreement") pursuant to which Silvercorp has agreed...

at 03:29
Company announcement No. 557, 2024 In accordance with Section 30 of the Capital Markets Act it is hereby announced that Nordea Funds Ltd, Finland, yesterday informed H+H International A/S that as per 22 April 2024 Nordea Funds Ltd. increased its...

at 01:26
Rickard Gustafson, President and CEO: "Our first quarter performance marked another step towards a more resilient and competitive SKF. In soft market conditions, we delivered a strong adjusted operating margin of 13.4%, somewhat ahead of Q1 2023. The...

25 avr 2024
AZZ Inc. , the leading independent provider of hot-dip galvanizing and coil coating solutions, today announced the pricing of its underwritten public offering of 4,000,000 shares of common stock at a public offering price per share of $70.00, for...

25 avr 2024
Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA*) ("the Company" or "Orbia") today released unaudited results for the first quarter of 2024. Orbia's first quarter performance reflects the continued weakness in the market environment,...

25 avr 2024
Vortex Metals Inc.  ("Vortex Metals" or the "Company") is pleased to announce that, further to its news releases dated April 11, 2024 and April 19, 2024, it has closed its previously announced non-brokered private placement (the "Private...



News published on and distributed by: